DeepMed Research

UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: Control Arm
Behavioral: iSTEP

First Posted Date: 2017-04-21

Last Posted Date: 2023-09-28

Lead Sponsor: University of California, San Diego

Target Recruit Count: 100

Registration Number: NCT03123731

Locations: 🇺🇸
HIV Neurobehavioral Research Program, San Diego, California, United States

Physical Activity and First Degree Female Relatives of Breast Cancer Patients

Not Applicable

Completed

Conditions: First-degree Relative With Breast Cancer
Female

Interventions: Behavioral: Physical Activity

First Posted Date: 2017-04-14

Last Posted Date: 2017-04-14

Lead Sponsor: University of California, San Diego

Target Recruit Count: 27

Registration Number: NCT03115658

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

Phase 1

Completed

Conditions: Richter's Syndrome
CLL

Interventions: Drug: Obinutuzumab
Drug: lenalidomide
Drug: HDMP

First Posted Date: 2017-04-13

Last Posted Date: 2022-07-05

Lead Sponsor: University of California, San Diego

Target Recruit Count: 4

Registration Number: NCT03113695

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States

Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain

Phase 2

Completed

Conditions: HIV Neuropathy
Pain Syndrome
Cannabis

Interventions: Drug: Cannabis

First Posted Date: 2017-04-04

Last Posted Date: 2024-06-18

Lead Sponsor: University of California, San Diego

Target Recruit Count: 5

Registration Number: NCT03099005

Locations: 🇺🇸
UC Center for Medicinal Cannabis Research, UC San Diego, San Diego, California, United States

Study of Food Aversion in Patients With Anorexia Nervosa

Not Applicable

Recruiting

Conditions: Anorexia Nervosa

Interventions: Other: A breakfast sandwich

First Posted Date: 2017-04-04

Last Posted Date: 2023-11-13

Lead Sponsor: University of California, San Diego

Target Recruit Count: 300

Registration Number: NCT03100656

Locations: 🇺🇸
UC San Diego Altman Clinical and Translational Research Institute, La Jolla, California, United States
🇨🇦
Program for Eating Disorders, Toronto General Hospital, Toronto, Ontario, Canada

FRESH-DOSE: Families Responsibility Education Support Health-Dual Options for Sustained Effectiveness

Not Applicable

Completed

Conditions: Overweight
Obesity

Interventions: Behavioral: Guided Self-Help Fam. Based Bx Treatment
Behavioral: Family Based Behavioral Treatment

First Posted Date: 2017-03-30

Last Posted Date: 2023-05-15

Lead Sponsor: University of California, San Diego

Target Recruit Count: 151

Registration Number: NCT03096132

Locations: 🇺🇸
UCSD Center for Healthy Eating and Activity Research (CHEAR), La Jolla, California, United States

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

Not Applicable

Completed

Conditions: Patient Adherence
HIV Seronegativity

Interventions: Behavioral: brief Motivational Interviewing

First Posted Date: 2017-03-22

Last Posted Date: 2021-09-13

Lead Sponsor: University of California, San Diego

Target Recruit Count: 263

Registration Number: NCT03086200

Locations: 🇺🇸
Los Angeles Lesbian, Gay, Bisexual, and Transgender Center, Los Angeles, California, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
University of California, San Diego, San Diego, California, United States

and more 2 locations

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Lip SCC
Oropharynx Cancer
Hypopharynx Cancer
Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Oral Cavity Cancer
Nasopharynx Cancer
Head and Neck Neoplasms
HNSCC
Larynx Cancer

Interventions: Drug: Pembrolizumab, Cetuximab

First Posted Date: 2017-03-17

Last Posted Date: 2023-04-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 78

Registration Number: NCT03082534

Locations: 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
UCSD Moores Cancer Center, La Jolla, California, United States
🇺🇸
University of California Los Angeles Cancer Center, Los Angeles, California, United States

and more 1 locations

KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)

Phase 3

Completed

Conditions: Mucocutaneous Lymph Node Syndrome

Interventions: Drug: IVIG
Drug: Infliximab

First Posted Date: 2017-02-27

Last Posted Date: 2021-12-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 105

Registration Number: NCT03065244

Locations: 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 26 locations

Lumbar Drain Vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage

Not Applicable

Recruiting

Conditions: Vasospasm, Intracranial
Subarachnoid Hemorrhage

Interventions: Device: Lumbar Drain
Device: Extraventricular Drain

First Posted Date: 2017-02-27

Last Posted Date: 2025-03-04

Lead Sponsor: University of California, San Diego

Target Recruit Count: 100

Registration Number: NCT03065231

Locations: 🇺🇸
UCSD Medical Center, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy